Manifold will use its tissue-targeting shuttle technology to help Roche develop new therapeutics for diseases of the central nervous system.
The most feasible reaction is between the nuclei of two heavy isotopes of hydrogen – deuterium (D) and tritium (T). This needs robust and efficient 14.1 MeV neutron detectors for monitoring and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback